1. Home
  2. LPL vs IOVA Comparison

LPL vs IOVA Comparison

Compare LPL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

N/A

Current Price

$2.98

Market Cap

3.3B

Sector

Technology

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$10.21

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPL
IOVA
Founded
1985
2007
Country
South Korea
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.7B
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
LPL
IOVA
Price
$2.98
$10.21
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
N/A
$9.00
AVG Volume (30 Days)
2.0M
13.0M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.35
$47.74
Revenue Next Year
$2.94
$40.31
P/E Ratio
$25.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$1.76
52 Week High
$5.83
$9.36

Technical Indicators

Market Signals
Indicator
LPL
IOVA
Relative Strength Index (RSI) 40.01 70.70
Support Level $2.76 $3.82
Resistance Level $3.43 N/A
Average True Range (ATR) 0.10 0.42
MACD -0.02 -0.01
Stochastic Oscillator 22.68 86.11

Price Performance

Historical Comparison
LPL
IOVA

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: